Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritisStinne Ravn Greisen, Bent Deleuran, TK Rasmussen et al.|Scandinavian Journal of Rheumatology|2013Cited by 114
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'Stinne Ravn Greisen, Malene Hvid, Karen Kræmmer Schelde et al.|Arthritis Research & Therapy|2014Cited by 81
Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.Stinne Ravn Greisen, Bent Deleuran, Holger Jon Møller et al.|PubMed|2011Cited by 62
Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitisKristian Aarslev, Henning Grønbæk, Anders Dige et al.|Scandinavian Journal of Gastroenterology|2016Cited by 48
Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid ArthritisStinne Ravn Greisen, Bent Deleuran, Yan Yan et al.|Frontiers in Immunology|2017Cited by 47